LSD Might Revolutionize the Future of Psychotherapeutic Drugs Market

Published Date : Apr 26, 2016

Psychotherapeutic drugs are prescribed to treat mental illnesses such as bipolar disorder, schizophrenia, anxiety and depression. Common symptoms of mental illness are social withdrawal, extreme mood swings, confused thinking, long lasting depression, and suicidal thought. While schizophrenia is associated with unrecognized speech, hearing voices, and broken thoughts, depression is characterized by lack of interest, confidence, and pleasure. 

The growing prevalence of mental illnesses has boosted the growth of the global psychotherapeutic drugs. The World Health Organization estimates that around 350 mn people are suffering from depression across the globe. Patent expiration of top selling psychotherapeutic drugs such as Geodon, Zyprexia, and Prozac has created growth opportunities for generic drug manufacturers. In the coming years, the generic drug segment is estimated to witness rapid growth and will lead to price competition in the market. 

Effect of LSD on Brain Analyzed for First Time

At the Imperial College of London, researchers have analyzed the effects of LSD on the brain with the help of various scans. The images have revealed significant neurological activity produced by the powerful drug. In partnership with the Beckley Foundation, the team of researchers took brain scan images of 20 volunteers who were given a dose of 75 micrograms of Lysergic acid diethylamide. The images taken with the help of fMRI and MEG revealed blood flow and electrical activity throughout the brain. To understand the real-life application of LSD’s psychotherapeutic potential in response to music, the research group also studied the drug’s effect on a volunteer’s experience of music. LSD is known to have a great impact on self-awareness in users. This might lead to greater implications for psychiatry in the coming days.